|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00417703 |
|
Date of registration:
|
03/01/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
|
|
Scientific title:
|
A Prospective Investigation of the Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab |
|
Date of first enrolment:
|
January 2007 |
|
Target sample size:
|
75 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00417703 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Scott J Westhouse, DO |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Oklahoma State University Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Male or Female Patients >18 years of age
2. Patients will have documented choroidal neovascular membranes on fluorescein
angiogram and/or optical coherence tomography
3. Requiring treatment or maintenance therapy for choroidal neovascular membrane
4. Able and willing to provide written informed consent
Exclusion Criteria:
1. History of arterial occlusive disease of the eye.
2. History of advanced glaucoma.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Choroidal Neovascularization
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|